Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 5;40(1):111041.
doi: 10.1016/j.celrep.2022.111041.

The structural mechanism of human glycogen synthesis by the GYS1-GYG1 complex

Affiliations
Free article

The structural mechanism of human glycogen synthesis by the GYS1-GYG1 complex

Nathan M Fastman et al. Cell Rep. .
Free article

Abstract

Glycogen is the primary energy reserve in mammals, and dysregulation of glycogen metabolism can result in glycogen storage diseases (GSDs). In muscle, glycogen synthesis is initiated by the enzymes glycogenin-1 (GYG1), which seeds the molecule by autoglucosylation, and glycogen synthase-1 (GYS1), which extends the glycogen chain. Although both enzymes are required for proper glycogen production, the nature of their interaction has been enigmatic. Here, we present the human GYS1:GYG1 complex in multiple conformations representing different functional states. We observe an asymmetric conformation of GYS1 that exposes an interface for close GYG1 association, and propose this state facilitates handoff of the GYG1-associated glycogen chain to a GYS1 subunit for elongation. Full activation of GYS1 widens the GYG1-binding groove, enabling GYG1 release concomitant with glycogen chain growth. This structural mechanism connecting chain nucleation and extension explains the apparent stepwise nature of glycogen synthesis and suggests distinct states to target for GSD-modifying therapeutics.

Keywords: CP: Molecular biology; structural biology, cryo-EM, Pompe disease, glycogen synthesis.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests N.M.F., Y.L., H.M., E.A., K.T.M., J.C.U., E.G., D.M., and C.T. are full time employees and stockholders of Maze Therapeutics. V.R., A.D.-R., and T.D.H. are advisors and stockholders of Maze Therapeutics.